Academician Li Zhaoshen: "Capsule endoscopy" makes the endoscopy of the gastroscopy painless

  Smart medical care is an inevitable trend of medical development in the future. Through the continuous improvement of technology, the practical value of intelligent robots in medical business scenarios has been initially recognized, but intelligent robots will still face enormous challenges to fully integrate into medical business scenarios.“Evidence-based data is an important criterion for validating the clinical value of medical robots. Li Zhaoshen, academician of the Chinese Academy of Engineering, president of the China National Physician Association, and director of the Department of Gastroenterology, Changhai Hospital, affiliated to the Naval Military Medical University, talked about medical treatment in the “Selection of the Most Influential Brands of Chinese Medicine Innovation” held in Suzhou on September 17th,when talking about the development of the robot said.

  Gastric cancer is a malignant tumor that seriously threatens the health of people in China and the world. According to data released by the 12th International Conference on Gastric Cancer (IGCC) in 2017, there are about 680,000 new cases of gastric cancer in China each year, accounting for about half of the global cases, and most patients have developed advanced gastric cancer at the time of diagnosis.

  Gastroscopic screening is an effective way to prevent gastric cancer, but the painful experience of traditional gastroscopy makes most people give it a wide berth.In order to resolve this contradiction, companies from all over the world have devoted themselves to the development of smart medical treatment, “capsule endoscopy”, but only today, China’s “Anhan Magnetic Control Capsule Gastroscope System” actually entered clinical use in 2013 and obtained Three types of medical device registration certificates issued by the drug regulatory authorities.At present, this technology has entered clinical application in thousands of medical institutions in 30 provinces and cities nationwide.

  “It is evidence-based data that supports its smooth entry into clinical applications.” Li Zhaoshen said: “Medical device innovation must advocate a serious academic spirit and must be based on complete clinical research data.”In terms of diagnostic accuracy, after a large sample, multi-center double-blind controlled experiment, the accuracy of the "Anhan magnetic capsule gastroscope" robot for gastric diseases was consistent with the height of the electronic gastroscope.

  It is reported that "Anhan Magnetic Control Capsule Gastroscope System" won the "Most Clinical Value Innovation Medical Device Award" in this selection activity.